Neurological: Headache, dizziness, fatigue, and somnolence (sleepiness/drowsiness), or temporary tiredness/yawning following injection
A new study says, via a mouse model, that muscle loss from GLP-1 medications like Ozempic may not be as high as recently thought
Protocol 3: the accelerated microdose (for mild sensitivity) Goal: Slightly gentler than standard without adding months to the timeline Best for: People with mild concerns about side effects, those who tolerated other GLP-1 medications like semaglutide but want a slightly easier start with tirzepatide Complete schedule: Weeks 1-2: 0.5 mg weekly Weeks 3-4: 1.0 mg weekly Weeks 5-6: 1.5 mg weekly Weeks 7-10: 2.5 mg weekly Weeks 11-14: 5.0 mg weekly Time to therapeutic dose: 10-14 weeks Expected results: Some mild nausea during the first two to three increases, clear appetite suppression by week 5, weight loss beginning around weeks 7-10 This protocol adds only a few weeks compared to standard titration but provides a meaningful buffer during the critical early weeks when side effects are most likely to drive people away from treatment
Between each numbered line are smaller lines representing individual units
This determines the final mg/mL concentration and, by extension, the unit measurements for every dose you take from that vial
Tier 2: Telemedicine clinics ($199-$425 per month)